Evidence map›Paper›PMID 28389487›Full record

Observational studyBMJ open2017

What is the care pathway of patients who undergo thyroid surgery in France and its potential pitfalls? A national cohort.

Muriel Mathonnet, Anne Cuerq, Christophe Tresallet, Jean-Christophe Thalabard, Elisabeth Fery-Lemonnier, Gilles Russ, Laurence Leenhardt, Claude Bigorgne, Philippe Tuppin, Bertrand Millat and 1 more

Abstract readObservational Study
In one paragraph

Observational study in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Sex Bias in Differentiated Thyroid Cancer.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Muriel MathonnetHospital of Limoges, Limoges, France.
Anne CuerqCaisse Nationale d'Assurance Maladie des Travailleurs Salariés, Paris, France.
Christophe TresalletDepartment of General, Visceral and Endocrine Surgery, Pitié-Salpêtrière Hospital, Paris, France.
Jean-Christophe ThalabardUnit of Gynecology and Endocrinology, Cochin Hospital, Paris, France.
Elisabeth Fery-LemonnierMinistry of Health, Paris, France.
Gilles RussDepartment of Thyroid Diseases and Endocrine Tumors, Pitié Salpêtrière Hospital, University Paris VI, Institut E3M, Paris, France.
Laurence LeenhardtDepartment of Thyroid Diseases and Endocrine Tumors, Pitié Salpêtrière Hospital, University Paris VI, Institut E3M, Paris, France.
Claude BigorgneDepartment of Pathology, La Pitié Salpétrière Hospital, Paris, France.
Philippe TuppinCaisse Nationale d'Assurance Maladie des Travailleurs Salariés, Paris, France.
Bertrand MillatLapeyronie Hospital, Paris, France.
Anne Fagot-CampagnaCaisse Nationale d'Assurance Maladie des Travailleurs Salariés, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe rate of thyroid cancer is increasing in France, as well as concerns about overdiagnosis and treatment.

objectivesTo examine the care pathway of patients who undergo thyroid surgery in France and detect potential pitfalls.

designA large observational study based on medical reimbursements, 2009-2011.

settingData from the Sniiram (National Health Insurance Information System). PATIENTS: Patients with thyroid surgery in 2010, classified into 4 groups: thyroid cancer, benign nodule, goitre or multiple nodules, other (hyperthyroidism, head-neck cancer).

main outcome measuresMedical investigations during, prior and after thyroidectomy.

resultsA total of 35 367 patients underwent surgery (mean age 51 years, 80% women): 17% had a reported diagnosis of thyroid cancer, 20% benign nodule, 38% goitre or multiple nodules and 25% another diagnosis. The ratio of thyroidectomies with cancer over thyroidectomies with benign nodule was 0.8 and varied across regions. In the year preceding surgery, 82% of patients had an investigation by thyroid ultrasonography, 21% thyroid scintigraphy, 34% fine-needle aspiration cytology, 40% serum calcitonin assay and 54% serum calcium assay. In the following year, all patients with total thyroidectomy and 44% of patients with partial thyroidectomy and a diagnosis of benign nodule were taking thyroid hormone therapy. 100 patients had been reoperated for a compressive haematoma and 63 died during the first month, half of whom had been operated for cancer. Mean rates of recurrent laryngeal nerve injury and hypocalcaemia (requiring blood tests plus treatments within 4-12 months) were estimated at 1.5% and 3.4%, respectively, and were higher in the cancer group (2.3% and 5.7%).

conclusionsThis almost nationwide study demonstrates the suboptimal management of patients prior to thyroidectomy in France. It suggests overdiagnosis and potential harms to patients, and calls for a review of the relevance of thyroidectomy, particularly with regard to microcancers.

Indexed as

Critical PathwaysThyroidectomyBiopsy, Fine-NeedleCalcitoninCalciumDatabases, FactualFemaleFranceGoiterHead and Neck NeoplasmsHormone Replacement TherapyHumansHyperthyroidismHypocalcemiaMaleMedical OveruseCalcitoninCalciumcanceroverdiagnosisSURGERY

Identifiers

PMID28389487
PMCPMC5558818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.